Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | PPIA | P62937 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclo(Prolylglycyl) SCHEMBL4247464 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL30768150 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL21736594 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL21736595 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| Cyclo(Prolylglycyl) SCHEMBL4243772 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL1189351 | 0.94 | ALDH1A1 (0.43) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL3519704 | 0.94 | ALDH1A1 (0.43) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL3519708 | 0.94 | ALDH1A1 (0.43) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL17516644 | 0.93 | KDM4E (0.43) | ALDH1A1KDM4EMAPTGAAKMT2A | |
| SCHEMBL464685 | 0.93 | KDM4E (0.43) | ALDH1A1KDM4EMAPTGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120129468-A | Composition for inhibiting amyloid beta accumulation | 三得利控股株式会社 | 2025-06-10 | — | — | CN | claimed |
| CN-119403556-A | Composition for immunomodulation | 三得利控股株式会社 | 2025-02-07 | — | — | CN | claimed |
| WO-2024158103-A1 | COMPOSITION CONTAINING STREPTOCOCCUS SP. STRAIN FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SKIN DISEASES | 코스맥스 주식회사 | 2024-08-02 | — | — | WO | claimed |
| CN-118126045-A | Method for preparing cycloglycyl proline from collagen oligopeptide and application of method | 中国海洋大学三亚海洋研究院 | 2024-06-04 | — | — | CN | claimed |
| CN-117567566-B | Liquid phase synthesis process of cyclohexapeptide-9 | 山东济肽生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117567566-A | Liquid phase synthesis process of cyclohexapeptide-9 | 山东济肽生物科技有限公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2024004931-A1 | IMMUNOMODULATION COMPOSITION | サントリーホールディングス株式会社 | 2024-01-04 | — | — | WO | claimed |
| CN-116685343-A | Use of cyclic dipeptides for the manufacture of agents that inhibit cognitive decline or improve cognitive dysfunction | 三得利控股株式会社 | 2023-09-01 | — | — | CN | claimed |
| EP-4081303-A1 | COMPOSITION CONTAINING CYCLIC DIPEPTIDE, PURINE NUCLEOSIDE AND/OR AMINO ACID, AND CHICKEN EXTRACT, PRODUCTION METHOD THEREOF, AND USE OF CYCLIC DIPEPTIDE, PURINE NUCLEOSIDE AND/OR AMINO ACID, AND CHICKEN EXTRACT | Suntory Holdings Limited (JP) | 2022-11-02 | — | — | EP | claimed |
| CN-115066273-A | Composition comprising cyclic dipeptide, purine nucleoside and/or amino acid and chicken extract, method for producing same and use of cyclic dipeptide, purine nucleoside and/or amino acid and chicken extract | 三得利控股株式会社 | 2022-09-16 | — | — | CN | claimed |
| EP-2594134-B1 | USE OF AN AGRICULTURAL AGENT CONTAINING 2,5-DIKETOPIPERAZINE DERIVATIVE AS ACTIVE INGREDIENT | REPUBLIC OF KOREA (MANAGEMENT: RURAL DEV ADMINISTRATION) (KR) | 2017-08-02 | — | — | EP | claimed |
| US-20130190177-A1 | AGRICULTURAL AGENT CONTAINING 2,5-DIKETOPIPERAZINE DERIVATIVE AS ACTIVE INGREDIENT | Kongju National University Industry- University Cooperation Foundation (KR) | 2013-07-25 | — | — | US | claimed |
| EP-2594134-A2 | AGRICULTURAL CHEMICAL CONTAINING 2,5-DIKETOPIPERAZINE DERIVATIVE AS ACTIVE INGREDIENT | Republic of Korea (Management: Rural Development Administration) (KR) | 2013-05-22 | — | — | EP | claimed |
| US-20100203154-A1 | Elasmobranch-Repelling Compounds, Methods of Use and Devices | STROUD ERIC MATTHEW | 2010-08-12 | — | — | US | claimed |
| EP-0751779-B1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORP (US) | 2001-12-19 | — | — | EP | claimed |
| EP-0751779-A4 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORP (US) | 1998-12-09 | — | — | EP | claimed |
| EP-0751779-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1995000165-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1995-01-05 | — | — | WO | claimed |
| EP-4743102-A1 | COLLAGEN PEPTIDE COMPOSITION AND USE THEREOF IN AMELIORATING NEUROLOGICAL CONDITIONS AND FIBROSIS | Rousselot BV (BE) | 2026-05-20 | — | — | EP | disclosed |
| US-3920660-A | Tetrahydropyrrolo{8 1,2-a{9 pyrazine-1(2H),4(3H)-diones | LEPETIT SPA | 1975-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100203154-A1 | Elasmobranch-Repelling Compounds, Methods of Use and Devices | ELOC, ELOVL3, ELOVL6 | ALDH1A1 2284/4885KDM4E 1578/4885MAPT 3604/4885 |
| US-20130190177-A1 | AGRICULTURAL AGENT CONTAINING 2,5-DIKETOPIPERAZINE DERIVATIVE AS ACTIVE INGREDIENT | HDHD5, DAZAP1, MAPKAPK5 | ALDH1A1 3568/4885KDM4E 1291/4885MAPT 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.